Prosecution Insights
Last updated: August 17, 2026

Examiner: YOUNG, MICAH PAUL

Tech Center 1600 • Art Units: 1618 1641

This examiner grants 55% of resolved cases

Performance Statistics

55.1%
Allow Rate
-4.9% vs TC avg
1,025
Total Applications
+29.8%
Interview Lift
1324
Avg Prosecution Days
Based on 978 resolved cases, 2023–2026

Rejection Statute Breakdown

1.5%
§101 Eligibility
17.5%
§102 Novelty
56.5%
§103 Obviousness
9.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18361064 NANO- OR MICROPARTICLE COMPRISING A POLYVINYL ALCOHOL MATRIX AND DISPERSED THEREIN, FERRITE, METHOD FOR PRODUCING THE SAME AND USES THEREOF Non-Final OA COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
18249663 MONOAMINE OXIDASE BLOCKADE THERAPY FOR TREATING CANCER THROUGH REGULATING ANTITUMOR T CELL IMMUNITY Final Rejection THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
18052354 CUSTOMIZABLE DOSAGE FORMS CONTAINING SIMETHICONE Non-Final OA Kenvue Brands LLC
17475794 NON-FIBROUS FILM AND CELL SHEET Non-Final OA Industrial Technology Research Institute
18612007 Carrier Systems For Cannabinoids Final Rejection Fertin Pharma A/S

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month